Rentokil Initial (ADR) (RTO)
Runs route-based pest-control and hygiene networks centred on North America.
Something off on this page? Send us feedback.
Provides pest-control and hygiene services through route-based networks, with Pest Control as the dominant activity. The Terminix combination made North America the largest operating centre, while recurring bolt-on acquisitions expand route density and the multi-year integration remains a core execution dependency.
Provides pest-control and Hygiene & Wellbeing services through route-based networks across North America and international markets. Pest Control is the dominant activity, covering rodents, insects, timber treatment and connected monitoring, while Hygiene & Wellbeing is the smaller reportable activity.
Builds service density by combining local field operations with bolt-on acquisitions. The Terminix combination made North America the group’s largest operating centre and added substantial US residential and termite exposure alongside the existing international network.
Execution depends on completing a multi-year integration across branches, systems, brands and operating practices without disrupting customers. The acquisition model also depends on absorbing local businesses while preserving customer relationships and route density.
Company facts
Target rangeAs of Sep 21, 2026
Latest analyst notes
| Date | Firm | Action | Prior | Current |
|---|---|---|---|---|
| Jul 31, 2026 | BNP Paribas | Target | Target: — | Target: $26.70 |
| Jul 31, 2026 | Exane BNP Paribas | Downgrade | Rating: — | |
| Jul 7, 2026 | Goldman Sachs | Upgrade | ||
| Jul 6, 2026 | Goldman Sachs | Upgrade | Rating: — | |
| Mar 12, 2026 | UBS | Upgrade |
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $2.49B · Total debt $6.18B · Total assets $14.64B · Shareholders' equity $5.55B
- Revenue
- $3.61B
- Operating income
- $351.0M
- Net income
- $197.1M
Reported in GBP, converted at the latest exchange rate
HistoryDividendAnnual yield
| Insiders | 5.36% | 27.10M ADS | |
|---|---|---|---|
| 1 holder · as of Nov 14, 2024 | |||
| Strategic holders | 18.89% | 95.44M ADS | |
| 3 holders · as of Apr 30, 2026 | |||
| Other | 75.75% | 382.66M ADS | |
| remainder | |||
505.21M ADS (1 ADS = 5 ordinary shares) as of Sep 22, 2026 · holders as of their latest filing
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
BlackRock Portfolio Management LLCStrategic | 6.93% | 35.02M | filed Apr 30, 2026 |
GIC Private LimitedStrategic | 6.32% | 31.93M | filed May 9, 2025 |
Janus Henderson Group PLCStrategic | 5.64% | 28.49M | filed Nov 14, 2025 |
Ein #.Insider | 5.36% | 27.10M | filed Nov 14, 2024 |
Insider tradesForm 4
Nothing filed in the last 12 months.
- Rollins
Largest listed pure-play rival across residential and commercial pest control
- Ecolab
Commercial pest and hygiene overlap across foodservice and regulated facilities
- Cintas
Route-based rival in restroom services, supplies, mats, and workplace hygiene
- Kimberly-Clark
Branded washroom consumables and dispensers competing with Initial Hygiene
Compare
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Rentokil Initial (ADR) | $21.66 | +1.40% | $10.75B | 22.7 | — | 1.5 | −21.7% |
| Rollins | $32.87 | +1.61% | $15.57B | 29.4 | 27.3 | 4.0 | +7.9% |
| Ecolab | $274.46 | +1.66% | $75.98B | 36.2 | 31.8 | 4.5 | +9.7% |
| Cintas | $196.64 | −0.12% | $78.79B | 40.1 | 35.7 | 7.0 | +8.9% |
| Kimberly-Clark | $99.06 | +1.35% | $32.44B | 16.6 | 14.1 | 2.0 | +0.6% |
| Median | 32.8 | 29.6 | 4.2 | +8.4% |